The store will not work correctly when cookies are disabled.
N'-(1-Naphthoyl)-2-methylimidazo[1,2-a]pyridine-3-carbohydrazide
ID: ALA3309662
PubChem CID: 27699376
Max Phase: Preclinical
Molecular Formula: C20H16N4O2
Molecular Weight: 344.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccccn2c1C(=O)NNC(=O)c1cccc2ccccc12
Standard InChI: InChI=1S/C20H16N4O2/c1-13-18(24-12-5-4-11-17(24)21-13)20(26)23-22-19(25)16-10-6-8-14-7-2-3-9-15(14)16/h2-12H,1H3,(H,22,25)(H,23,26)
Standard InChI Key: UFGNAQNKTJBWOW-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
0.9563 -3.8025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1594 -4.0160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0541 -4.8129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5292 -5.3962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3261 -5.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5396 -4.3858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3308 -3.0674 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1457 -3.1964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2747 -4.0113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0098 -4.3858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0530 -5.2097 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7243 -3.9733 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4387 -4.3858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7290 -2.6131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1532 -3.1483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4387 -2.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4387 -1.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1532 -1.4983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8677 -1.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5821 -1.4983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2966 -1.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2966 -2.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5821 -3.1483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8677 -2.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1532 -3.9733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8677 -4.3858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
6 9 1 0
1 7 2 0
12 13 1 0
10 11 2 0
10 12 1 0
9 10 1 0
8 14 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
15 24 2 0
19 24 1 0
15 25 1 0
25 26 2 0
13 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.37 | Molecular Weight (Monoisotopic): 344.1273 | AlogP: 2.87 | #Rotatable Bonds: 2 |
Polar Surface Area: 75.50 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.11 | CX Basic pKa: 4.38 | CX LogP: 1.92 | CX LogD: 1.91 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -1.89 |
References
1. Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.. (2014) Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 22 (15): [PMID:24953948] [10.1016/j.bmc.2014.05.038] |